Drugmakers aim to curb release of antibiotic waste into the environment

New guidelines put forth by a pharmaceutical coalition aim to limit the overexposure to antibiotics that increases resistance – a problem costing a million lives a year across the globe.

Photo: Daniel Karmann/AP/Ritzau Scanpix

A coalition of drugmakers is introducing new standards aimed at curbing the release of antibiotic waste into the environment amid growing concerns over drug resistance that’s been linked to more than a million annual deaths globally.

The guidelines will help ensure antibiotics are made responsibly, minimizing environmental risks, the AMR Industry Alliance said Tuesday in a statement. The group also plans to launch a certification program next spring that will allow manufacturers to show requirements have been met through independent evaluation, initially by UK-based BSI Standards Limited.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Further reading

Related articles

Latest news

See all jobs